United States
Germany
Japan
United Kingdom
China
Antibodies
Anti-CD3e Reference Antibody (teplizumab)
| Applications | Animal Model, ELISA, FACS, FN, Kinetics |
| Reactivities | Human |
Anti-CD3e Reference Antibody (foralumab)
| Applications | Animal Model, ELISA, FACS, FN, Kinetics |
| Reactivities | Human, Mouse |
Recombinant Anti-CD3 epsilon (Clone 500A2)
| Applications | FC |
| Reactivities | Mouse |
Recombinant Anti-CD3 epsilon (Clone 12F6)
| Applications | FC |
| Reactivities | Human |
Recombinant Anti-CD3 epsilon (Clone YTH 12.5)
| Applications | IF, IHC, WB |
| Reactivities | Human |
Recombinant Anti-CD3 epsilon (Clone 145-2C11)
| Applications | FC, IP, WB |
| Reactivities | Mouse |
Recombinant Anti-CD3 epsilon (Clone 145-2C11)
| Applications | FC, IP, WB |
| Reactivities | Mouse |
Recombinant Anti-CD3 epsilon (Clone 145-2C11)
| Applications | FC, IP, WB |
| Reactivities | Mouse |
Recombinant Anti-CD3 epsilon (Clone UCHT1)
| Applications | FC, IHC |
| Reactivities | Human |
Recombinant Anti-CD3e (Clone 898H2-6-15)
| Applications | FC, IHC |
| Reactivities | Pig |
Recombinant Anti-CD3 epsilon (Clone 500A2)
| Applications | FC |
| Reactivities | Mouse |
Recombinant Anti-CD3 epsilon (Clone OKT-3 (muromonab))
| Applications | FC |
| Reactivities | Human |
